Category Archives: Neurotechnology

BTIG analyst Ryan Zimmerman maintained a Buy rating on Stryker Corporation (NYSE:) on Thursday, setting a price target of $284, which is approximately 5.77% above the present share price of $268.5.

Zimmerman expects Stryker Corporation to post earnings per share (EPS) of $1.57 for the fourth quarter of 2021.

The current consensus among 5 TipRanks analysts is for a Strong Buy rating of shares in Stryker, with an average price target of $301.75.The analysts price targets range from a high of $320 to a low of $284.

In its latest earnings report, released on 06/30/2021, the company reported a quarterly revenue of $4.29 billion and a net profit of $808 million. The company's market cap is $101.25 billion.

According to TipRanks.com, BTIG analyst Ryan Zimmerman is currently ranked with 5 stars on a 0-5 stars ranking scale, with an average return of 23.9% and a 56.41% success rate.

Michigan-based Stryker Corp. was founded in 1941. The company provides medical technology products and services. It operates its business through the following segments: Orthopaedics, MedSurg and Neurotechnology and Spine.

Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.

Read the original here:

BTIG Stick to Their Buy Rating for Stryker Corporation By Investing.com - Investing.com

Otology Drills Market Introduction

Otology drill is a surgical equipment primarily used during otologic procedures. Otology drills are available with different operating speeds, ranging from 16,000 rpm to 85,000 rpm, as per the need and requirement of otologic procedure. These drills feature straight and angled attachments to achieve desired flexibility, surgical access & visibility, and irrigation systems, and are power driven. These are available in different types of surgical bur attachments to serve required purpose of otology surgeries.

Read Report Overview - https://www.transparencymarketresearch.com/otology-drills-market.html

Global Otology Drills Market - Competitive Landscape

The global otology drills market is consolidated, with small number of players holding majority share in respective regions. New product development & commercialization and mergers & acquisition are the key trends observed in the global otology drills market.

Request Brochure of Report - https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=71742

Medtronic plc

Medtronic plc is a diversified medical device company engaged in the manufacture of a range of medical devices & technologies. The company develops and markets products and therapies in the areas of cardiac rhythm disorders, cardiovascular diseases, neurological disorders, spinal conditions, ENT surgeries, and diabetes. It operates business through four functional divisions: Cardiac & Vascular Group, Minimally Invasive Therapies Group, Restorative Therapies Group, and Diabetes Group. The company offers four different types of otology drills in its product portfolio: Indigo Otology Drills, Visao High-Speed Otologic Drill, and Midas Rex Legend Stylus Surgical Drills.

Request for Analysis of COVID-19 Impact on Otology Drills Market- https://www.transparencymarketresearch.com/sample/sample.php?flag=covid19&rep_id=71742

Stryker Corporation

Stryker Corporation is a global medical devices company that operates through three business segments: orthopedics, MedSurg, and neurotechnology & spine. The company is a leading player in the medical devices industry. It offers a range of products such as implants employed in orthopedic, trauma, and replacement surgeries; endoscopic and communication systems; emergency medical equipment and intensive care disposable products, and surgical equipment & surgical navigation systems. The company offers S2 Drive Drill and S2 Mini Drill System in the otology drills market.

DePuy Synthes

DePuy Synthes is a part of Johnson & Johnsons medical device segment. The company offers joint reconstruction solutions for knee, hip, and shoulder joints. DePuy Synthes offers a range of solutions addressing key areas of spine surgery such as cervical, thoracolumbar, ENT surgery, aging spine, minimally invasive surgery, and interbody fusion. The company operates across the world through its direct sales force, independent sales agents, and distributors. The company offers ANSPACH EMAX 2 Plus System and Anspach High Speed Drill System in the otology drills market.

Request for Custom Research - https://www.transparencymarketresearch.com/sample/sample.php?flag=CR&rep_id=71742

CONMED Corporation

CONMED Corporation is a global medical technology company engaged in the development, manufacture, and marketing of surgical and patient-monitoring devices for minimally invasive procedures. The companys products and technologies have wide usage in the following medical specialties: orthopedics, laparoscopy, robotic and open surgery, gastroenterology & pulmonology, cardiology, ENT surgery, and critical care. CONMED Corporation operates through three business segments: orthopedic surgery, general surgery, and surgical visualization.

Other leading players operating in global otology drills market include Olympus Corporation, NOUVAG AG, KARL STORZ, SPIGGLE & THEIS Medizintechnik GmbH, and Bien-Air Surgery SA.

Pre Book Otology Drills Market Report - https://www.transparencymarketresearch.com/checkout.php?rep_id=71742&ltype=S

Otology Drills Market - Dynamics

High Prevalence and Incidence Rates of Hearing Loss to Drive Market

The global otology drills market is primarily driven by high prevalence of hearing loss. According to the Hearing Loss Association of America (HLAA), hearing loss is considered to be the third most common physical condition after arthritis and heart disease, affecting people of all ages. Gradual hearing loss can affect people of all ages differing from mild to profound. It can be mild or severe, temporary or permanent, depending on the cause. According to the WHO, a person who is unable to hear as well as someone with normal hearing hearing thresholds of 25 dB or better in both ears is considered to have hearing loss. Moreover, in 2019, nearly 466 million people across the world are likely to have disabling hearing loss. Among them, 93% are anticipated to be adults and 7% children. Among adults, more men (56%) than women (44%) are expected to have disabling hearing loss. Hence, high prevalence of hearing loss is projected to fuel the growth of the global otology drills market during the forecast period.

Technological advancements in the development of otology drills, such as high speed otology drills, compatibility of different sized otology burs, and development of integrated power systems are anticipated to boost the growth of the market during the forecast period.

More Trending Reports by Transparency Market Research:

Oncolytic Virus Immunotherapy Market Due to advancements in medical science and technology, at present, immunotherapy is at the helm of modern oncology care due to which, the deployment of oncolytic virus immunotherapy has witnessed consistent growth.

Urodynamics Equipment and Disposables Market Urodynamic testing forms the foundation of investigation pertaining to lower urinary tract dysfunction. However, amidst the COVID-19 (coronavirus) pandemic, healthcare providers are adapting to new urodynamics procedures to establish quality control in healthcare settings.

Hepatitis E Diagnostic Tests Market The growth of hepatitis E diagnostic tests market in Latin America is expected to be modest, owing to the hyper-endemicity of the disease in certain regions and the growing tourism, leading to the movement of people from hyper-endemic and endemic regions to non-endemic regions.

About Us

Transparency Market Research is a next-generation market intelligence provider, offering fact-based solutions to business leaders, consultants, and strategy professionals.

Our reports are single-point solutions for businesses to grow, evolve, and mature. Our real-time data collection methods along with ability to track more than one million high growth niche products are aligned with your aims. The detailed and proprietary statistical models used by our analysts offer insights for making right decision in the shortest span of time. For organizations that require specific but comprehensive information we offer customized solutions through ad hoc reports. These requests are delivered with the perfect combination of right sense of fact-oriented problem solving methodologies and leveraging existing data repositories.

TMR believes that unison of solutions for clients-specific problems with right methodology of research is the key to help enterprises reach right decision.

ContactMr. Rohit BhiseyTransparency Market ResearchState Tower,90 State Street,Suite 700,Albany NY - 12207United StatesUSA - Canada Toll Free: 866-552-3453Email: sales@transparencymarketresearch.comWebsite: https://www.transparencymarketresearch.com/

Visit link:

Otology Drills Market: High Prevalence and Incidence Rates of Hearing Loss to Drive Market - BioSpace

This article originally appeared in issue 21of IT Pro 20/20,available here. To sign up to receive each new issue in your inbox,click here

COVID-19 has created an unprecedented shift in the way we work, forcing millions to leave the workplace behind in favour of cobbled together home office spaces and virtual meetings. While this transition was disruptive at first, Ernst & Young research reveals nine in ten employees want the flexibility its brought to continue post-pandemic. This has led many organisations to embrace a hybrid approach, whereby employees split their time between home and the workplace.

Its clear, however, that offices need to adapt as people prepare to return. As a result of remote working, employees have enjoyed clear productivity benefitsfuelled by technologies such as video conferencing and cloud-based collaboration software. Many will also fear a return to twice-daily commutes and in-person meetings could cause them to feel burned out so solutions will need to be employed to ensure employees dont resent returning to the office.

One way to project what the office of the future will look like is to understand peoples remote work experiences over the last 18 months. According to Hyperoptic, the future of the workplace is technology-driven, with nearly two thirds of Brits (59%) saying theyd like to see new technologies introduced into their offices within the next 12 months. More specifically, 20% are calling for more Internet of Things (IoT) tech, 14% for 3D printing and 13% for virtual reality (VR) teleconferencing devices.

Zoom and Microsoft Teams enjoyed unparalleled success during the pandemic and quickly became household names. Employees, however, are beginning to tire of these tools, with Microsoft CEO Satya Nadella even warning of the risk of video call fatigue caused by back-to-back meetings. To combat this growing issue, businesses need conferencing tools that better engage their hybrid workforce, according to Dennis Shafranik, a partner at investment firm Concentric.

Zoom-esque solutions are still not that great or engaging, are tiring for people to use, and dont translate context or emotions.This makes it tough to build lasting trust through, Shafranik tells IT Pro. A cool example of technology that could transform video conferencing is Googles pilot, Project Starline, which creates a live, 3D video-image of a remote colleague, and comes much closer to recreating a true in-person meeting.

A variety of telepresence and telerobotics are also being developed, to enable workers to feel physically within a space alongside their colleagues. An example is Double Robotics, which is essentially an iPad on a robotic arm, and too expensive for most businesses at present. However, in the coming years, well see developments to improve these innovations, to make them more affordable and efficient. And there is certainly an opportunity in the market, with organisations looking to boost home productivity now normal office life has resumed.

Shaping the workplace of the future

Businesses must cater for the data demands of mobile, social and the IoT without disrupting day-to-day operations or security...

Narinder Sahota, CTO at IT company Advanced, agrees, adding that attempts to foster a virtual employee experience, be it through Teams or Slack, has rapidly turned into an app overload nightmare, with innovative technologies required to make the experience more personal. People, at the moment, are struggling to distinguish the wood from the trees.

As such, he continues, we are going to see businesses simplify and personalise technology in the workforce. Were already seeing Google test its ideas for the office of the future with its prototype hot desk of the future, with desks that adjust to a users personal preferences, as well as 3D meetings and inflatable privacy walls made of cellophane.

This app overload nightmare is also causing employees to burn out; an issue only set to get worse as they return to the workplace. Dr Jamil El Imad, chief scientist at NeuroPro, believes his Dream Machine a VR system that uses advanced signal processing techniques to monitor the brain and other bio-data could be the answer. After recognising the potential of VR, he worked on using cloud computing to capture and analyse brain activity. The end result is a machine that simulates the meditation experience.

I believe the future offices primary function is to heal and to re-humanise the work environment and entrench a culture of compassion and individuality, El Imad tells IT Pro. The deeper we connect not only with our minds but with our hearts too, the more motivated and empowered we become to outperform.

His Dream Machine reads neural activity in real-time and curates a natural experience that reflects a users changing state of mind. Its a mind gym, El Imad explains, designed to help us focus in a fun way using VR and neurotechnology. One example involves beaming a user to a tropical island. The mission, in this exercise, is to use the power of the mind to clear the heavy fog on the island; only by concentrating can you clear the fog and enjoy the natural beauty. Essentially, he says, youre rewarded with a feeling of weightlessness by relaxing and breathing naturally. Following this exercise, users receive a performance score based on how well they concentrated and how relaxed they were.

We know that wellness, physical and mental, is key to performance and resilience is key to prevention. We also know that mental resilience can be trained so its time we pay attention to our mind and lift our mental resilience to help us cope better in this fast changing, uncertain world.

Office-based workers arent the only ones set to see technology change the way they work. Innovation will also revolutionise so-called deskless jobs such as those held by nurses, cleaners and field engineers which currently still rely on paper-based checklists and outdated spreadsheets.

Kit Kyte, CEO of workflow software firm Checkit, tells IT Pro that although headlines claim most workers want a split between office and home working, the reality is most employees work neither at an office nor at home. In fact, 80% of working people are deskless, he says. All the talk of hybrid models, video-conferencing and file sharing is lost on that population because theyve been excluded from the digital conversation. But theres a groundswell of change. Businesses are starting to recognise the impact deskless workers have on overall productivity, customer experience, safety standards, efficiency and waste reduction. Those that are digitally enabling their deskless workers and connecting disparate data sources will have an advantage in the future.

Kyte adds well move from command-and-control structures to allowing frontline teams to make data-driven decisions. Staff will also have greater autonomy, instead of following paper-based checklists. Cleaners, for example, wont slavishly follow hourly schedules, rather theyll be prompted to attend sites based on footfall data from smart building systems. Theyll no longer work in isolation but as part of a wider digital ecosystem, with innovative businesses combining IoT and automation with digital assistants to eradicate dark operations.

Steve Black, co-founder and chief strategy officer of Topia, even believes that such technologies could create deskless jobs from those currently in office-based roles. We expect to see a future of work where flexible working takes on an entirely new meaning. In that world expect to see fluid global teams, with rapidly changing footprints and a wider scope of mobility, he tells IT Pro. Teams will form around a specific role or task for a company, so for a certain time period individuals will be plugged into an organisation but may then leave once the task is completed and move onto a different team or role.

Consequently, headquarters will shrink with more satellite offices popping up as they embrace location agnostic teams with sophisticated talent and project management software that will use AI and predictive analytics to proactively identify market opportunities, then assign resources. So rather than flexiwork it will become a flexi-task workforce. Employees will be attracted to a role or assignment because of the fulfilment it offers and the experience and career opportunities it offers. For governments and employers this will mean an even bigger focus on connectivity, local facilities to meet-up and having the right tools to collaborate, but also they will need to understand where we live will be more determined by quality of life than what job opportunities it might offer.

Next-generation time series: Forecasting for the real world, not the ideal world

Solve time series problems with AI

The future of productivity

Driving your business forward with Microsoft Office 365

How to plan for endpoint security against ever-evolving cyber threats

Safeguard your devices, data, and reputation

A quantitative comparison of UPS monitoring and servicing approaches across edge environments

Effective UPS fleet management

View post:

How the pandemic has shaped the office of the future - IT PRO

The round table Neurotechnologies and Human Rights framework: Do we need new rights? will take place online on 09 November 2021 (10.00 17.00 CET).

The event is co-organised by the Council of Europe and the OECD, with the participation of UNESCO. It is held in the context of the launch of the Council of Europe Strategic Action Plan on Human Rights and Technologies in Biomedicine (2020-2025) and the implementation of the 2019 OECD Recommendation on Responsible Innovation in Neurotechnology.

The discussion of the round table will tackle the most pertinent questions raised with application of neurotechnologies in medical and non-medical fields from the standpoint of human rights, such as privacy, freedom, integrity and non-discrimination.

More information is available on the event, including Report of the Council of Europe on Common Human Rights Challenges raised by Different Applications of Neurotechnologies in the Biomedical Field, the Programme of the event, and the Registration form.

The round table will be open for public upon registration done before 07 November 2021.

More information:

Follow us on social media:

Original post:

Neurotechnologies and Human Rights framework: Do we need new rights? - Council of Europe

image:Illinois Institute of Technology Professor of Biomedical Engineering Philip Troyk view more

Credit: Illinois Institute of Technology

During a visit to Illinois Institute of Technologys Mies Campus in Chicago, Governor J. B. Pritzker announced that the State of Illinois would be providing $1.5 million to the Pritzker Institute of Biomedical Science and Engineering at Illinois Institute of Technology (Illinois Tech) to renovate 2,770 square feet of existing Illinois Tech wet lab space to create a specialized multi-tenant laboratory called the Neurotissue and Organoid Innovation Laboratory (NOIL) for advanced research in translational neurotechnology.

Our state is a national hub for entrepreneurship and innovation because of leaders like Illinois Tech paving the way forward for the talent and technology of tomorrow. The more that we can do to support your mission here at Illinois Tech, the better off well all be in the state of Illinois and in the United States, says Pritzker. This investment creates opportunities to advance IITs research and to provide a range of much-needed scientific, regulatory, and business development services to startups investing in cutting-edge research.

Pritzker selected Illinois Tech as one of eight wet labs across the state to receive funding through the Rebuild Illinois Wet Lab Capital Program, and Illinois Tech will match the $1.5 million that the state provided.

Pritzker says he believes this funding for Illinois Tech serves as an investment not just in the university but in its broader community, which includes its partner institutions such as Malcolm X College, whose representatives attended the governors announcement.

Todays grants are an exemplification of what happens when a very supportive government helps higher ed do what it does best by bringing people together and by doing cutting-edge research that solves the grand challenges of our times while at the same time empowering diverse learners with the skills so that they can thrive in the future world, says Raj Echambadi, president of Illinois Tech.

NOIL will offer researchers, medical startups, and companies across the country access to advanced equipment and facilities to conduct fundamental studies supporting the development of novel medical therapies.

Our goal for the laboratory is to enhance the state of Illinoiss regional capabilities to attract, support, and facilitate growth of small businesses, startups, entrepreneurs, and university collaborators who are part of a rapidly growing neurotech sector, says Executive Director of the Pritzker Institute, Robert A. Pritzker Endowed Chair in Engineering, and Professor of Biomedical Engineering Philip Troyk. From state-of-the-art visual prosthetics to Illinois Techs brain atlas project, this new facility will allow Illinois Tech and the state of Illinois to play a central role in the development of truly life-changing biomedical advances.

NOIL is a crucial component of the newly formed Functional Neural Technology Center, which will provide one-stop-shop services to growing companies, entrepreneurs, and emerging academic collaborations that are pursuing cutting-edge clinical translation in the field of neurotechnology.

The renovated wet lab will provide the facilities essential to advance the development of neural implant technology such as the world-leading visual prosthesis developed at Illinois Tech. It will also serve the emerging field of bioelectronic medicine, which promises to substitute traditional drug therapies by creating implanted neural-modulation medical device interfaces to nerves that control human organs.

The remodeling of wet labs for specialized neural tissue and organoids will provide new fundamental and functional wet laboratory space for multiple users and create an unprecedented capability within Chicago for the support of collaborative neural technologies research.

Troyk, who has developed a first-of-its-kind visual prosthesis system, says, Making that transition from an idea to a clinical deployment is not easy. Illinois Tech is launching an initiative that will assist those who are developing these novel therapies in order to navigate the pathway from concept to clinic.

As part of the Illinois Tech and City Colleges of Chicago partnership, Malcolm X College will provide its students with opportunities to learn and conduct research in the renovated wet lab space.

David Sanders, president of Malcolm X College, says, Illinois Tech has a history of working with City College faculty to develop transfer agreements and offering City College students generous scholarships. Our involvement in the wet lab research space is the next step in our powerful, powerful relationship.

Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.

Read the rest here:

Illinois Tech awarded state government funding to develop the Neurotissue and Organoid Innovation Laboratory - EurekAlert

Sens.ai has built heart coherence training into its breakthrough neurofeedback system to help reduce record stress levels and increase happiness

WHISTLER, B.C., Oct. 21, 2021 /PRNewswire-PRWeb/ -- Sens.ai, a personalized neurotechnology company, will soon launch its wearable headset that utilizes a Pulse Oximeter sensor to treat stress by not only measuring heart rate variability (HRV) but also training it. Sens.ai uses a headset and app to read heart signals and translate them into audiovisual cues, acting like a mirror for the mind and heart. Sens.ai's personalized training approach is supported by decades of research and clinical work on increasing physiological adaptability and mental wellbeing.

Sens.ai is arriving at an optimal time, slated for consumer launch in Q2 2022. According to the American Psychological Association, American adults report feeling more stressed today than ever before. 47% of adults have reported feeling anxiety, 44% feel sadness, and 39% feel extreme anger. Additionally, 67% of adults said the number of issues America is facing is overwhelming to them.

Sens.ai's innovative headset is designed to bring a full suite of clinically-developed neuro training to the consumer in the comfort of their own home, and into the palm of their hands. The system both trains and stimulates the central nervous system through audiovisual cues and light therapy, with real-time reading and adapting to both the heart and brain's activity. Sens.ai's unique brain and heart workout clears brain fog, helps calm your nervous system for sound sleep and builds memory capacity.

"We believe that through Sens.ai, anyone can finally have access to world-class neuro-optimization technology in the comfort of their own home and at an approachable cost," said Paola Telfer, CEO, and founder of Sens.ai. "One of the many benefits of Sens.ai is the ability to reduce stress and increase happiness. Many people struggle to reduce stress levels quickly and long term. This is where Sens.ai comes into play, utilizing personalized HRV and neurofeedback training technology; it empowers people to quickly summon calm when they feel stress and more importantly, train calm as a long-term, substance-free habit. "

Story continues

Managing their stress response allows people to perform better and increase happiness. Heart rate variability training, is also referred to as heart coherence training. This state of heart coherence occurs when your heart rate smoothly moves up and down like the rise and fall of a wave. This state of heart coherence is incredibly peaceful and calming. A high HRV is a known indicator of a flexible and balanced central nervous system.

Training with Sens.ai not only helps users increase their HRV over time but can also teach them how to enter a state of heart coherence. The HRV training can be used on its own, or as a primer to improve the brain's response to a neurofeedback session. By using Sens.ai's programs, the mind-body connection and overall cognitive function will be strengthened.

To learn more, please visit http://www.sens.ai.

About Sens.ai Sens.ai is an adaptive brain training system designed to help people rewire their brain for peak performance in the comfort of their own home. Through its innovative headset, packed with technological innovations, the system provides real-time feedback to continually personalize training and challenge the mind's potential. Sens.ai has the unique ability to provide objective functional testing from home so you can track changes as you expand your mental flexibility and awaken your genius. For more information visit http://www.sens.ai.

Media Contact

Elyse Johnson, Sens.ai, 6202023037, pr@sens.ai

SOURCE Sens.ai

See the article here:

Sens.ai is The First At-Home Neuro-Optimization System to Incorporate Heart Coherence Training With Brain Training to Help People Manage Stress -...

Newest Hardware Release Muse S (Gen 2) Uses "Smart Fade" Technology to Sense When You Awaken During The Night and To Automatically Deliver A "Digital Sleeping Pill" To Help Get You Back to Sleep Faster

TORONTO, October 20, 2021--(BUSINESS WIRE)--Interaxon Inc. (Muse), a leading consumer neurotechnology and meditation company, today announced the launch of the second generation of its popular EEG meditation & sleep headband, Muse S. This updated plush brain-sensing headband uses real-time biofeedback to help you learn the art of mediation as well as help you fall asleep, stay asleep and now go back to sleep if you awaken during the night.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20211020005215/en/

Muse today announced the launch of the second generation of its popular EEG meditation & sleep headband, Muse S. This updated plush brain-sensing headband uses real-time biofeedback to help you learn the art of mediation as well as help you fall asleep, stay asleep and now go back to sleep if you awaken during the night. (Photo: Business Wire)

Alongside the launch of the updated Muse S headband, Interaxon is launching an intelligent new kind of EEG-powered sleep experience that is designed to help put you to sleep and guide you back to sleep if youve woken during the night.

Interaxon has been excited to offer this never-before-seen sleep intervention after building on their successful release of sleep content & EEG sleep tracking insights to support healthy sleep habits. A recent 2021 study led by Western University, Cambridge Brain Science, Hatch, and Interaxon that used Muse S EEG-sleep support technology showed a 20% improvement in the Pittsburgh Sleep Quality Index, relative to controls wanting to improve their sleep.

"For many of us, increasingly busy days translate into busy minds at night and restless sleep. While sleep tracking can be helpful to gain insights on trends and changes in your sleep quality, tracking your sleep doesnt provide immediate relief when you need it most," said Walter Greenleaf, Chief Science Officer at Interaxon (Muse). "According to the CDC, more than a third of American adults are not getting enough sleep on a regular basis with less than seven hours per day.1 This innovative new solution can help users get the rest they need to improve their overall wellness with a non-pharmaceutical sleep aid."

Story continues

Digital Sleeping Pills (DSPs)

Muse Digital Sleeping Pills or DSPs are designed to help you through the wind-down process by responding to your brains rhythms and helping you disengage from your busy mind. Muse S detects the natural changes in your brain activity as you fall asleep and uses those changes to gently fade out your audio to cue your brain that its time for sleep. If you wake in the night, Muse S uses the same Smart-Fade technology to automatically fade in the DSP content to guide you back to sleep again.

Sleep content preferences can vary widely from person to person. Some people are looking for a more engaging story to keep their mind from getting stuck in ruminating thoughts, while others may find a story too exciting to fall asleep to and prefer a softer, guided meditation or ambient soundscape. Depending on what type of content helps you fall asleep best, you can select a variety of different DSPs to help you on your journey including all-new:

Original, Classic, and Adventure Sleep Stories that have a voice narration of some of your favorite childhood stories & a variety of new original stories

Ambient Sleep Soundscapes that offer soothing ambient music and harmonized sounds without a voice narrative

Biofeedback Sleep Soundscapes that offer nature sounds and music that respond to biofeedback without a voice narrative

Guided Sleep Meditations that have a meditation teacher guide you through a relaxing sleep meditation

In addition to the advanced EEG technology that Muse is known for, the all-new second-generation Muse S has improved signal quality for increased accuracy and enhanced battery performance with up to 50% reduction in charging time. Additionally, improved fit for a wider range of head sizes has been achieved with the same comfortable, adjustable, and washable fabric band.

Pricing and Availability

Muse S (Gen 2) is now available for $399.99 USD at http://www.choosemuse.com and will be available on Amazon North America starting in 2022. Both first and second-generation Muse S headbands will have access to the new Digital Sleep Pill (DSP) features free of charge with Gen 1 users gaining access in December of 2021.

To unlock Biofeedback+ and unlimited access to 500+ meditations with new content released monthly, you can subscribe to the Muse Premium Subscription for $12.99 USD per month or $94.99 USD per year.

In addition to a rich content library of more than 500 meditations from renowned meditation teachers, unlock access to a variety of relaxation techniques, Go-to-Sleep soundscapes, and in-depth courses with step-by-step instructions, such as The Sleep Basics course by Dr. Shelby Harris, an expert in behavioral sleep medicine. Additionally, youll have access to Biofeedback+ which is designed to allow you to see how your brain and body responds to external content whether it be music in Spotify, Audiobooks, or meditations in Headspace.

Now available at http://www.choosemuse.com.

About Muse by Interaxon Inc.:

At Muse, our team of neuroscientists, meditation teachers, and engineers based out of Toronto who develop state-of-the-art experiences using research-grade EEG technology. Our goal is to help individuals build a rewarding meditation practice and live healthier, happier, more connected lives through human-centered technology. Our award-winning neurofeedback devices, and premium content offering of guided meditations with responsive learning functionality, is designed to help users meditate by providing real-time audio feedback on their meditative state through the Muse companion app. We make the intangible, tangible. Muse is headquartered in Toronto, Canada, and has subsidiaries in the U.S. and Ireland.

More information about Muse is available at http://www.choosemuse.com.

Milestones were excited about:

More than 500,000 Musers globally

Accessible: Muse is available in four languages, including English, Spanish, French and German

Sessions of meditation with Muse: Over 100 million minutes to date and currently one of the largest brain data (EEG) collections in the world.

Research institutions using Muse: The Mayo Clinic, NASA, Harvard, MIT, U of T, UCL, UCSD, Inria, UVic, UBC, and many more.

Meditating with Muse works: Muse has been used in over 200 published studies, including Mayo Clinic who demonstrated meditating with Muse increases quality of life, and decreases stress and fatigue in cancer patients.

Untangle Podcast: With more than 7 million plays, Untangle hosts Patricia Karpas and Ariel Garten interview thought-provoking authors, experts and leaders in areas related to mindfulness, sleep, neuroscience, brain health practices, and more.

View source version on businesswire.com: https://www.businesswire.com/news/home/20211020005215/en/

Contacts

Hanna Thorntonmuse@maxborgesagency.com

Go here to read the rest:

Interaxon Inc. (Muse) Launches the Latest in Non-Pharmaceutical Sleep Support: EEG-Powered Digital Sleeping Pills That Provide Immediate &...

In a biometrics development that might generate some resistance among the AI skeptical, Belgian researchers have demonstrated authentication using brain waves. The waves are like fingerprints or vein patterns unique and detailed.

They used electroencephalography, or EEG, on 15 healthy people and recorded an authentication accuracy rate of 92.6 percent, a false acceptance rate of 2.5 percent and a false rejection rate of 5 percent in one set of tests.

The subjects went through a multitask scheme in which they performed and imagined motor tasks, according to the research teams paper. The researchers used a long short-term memory or LSTM-based recurrent neural network with a bagging or bootstrap aggregation technique to mitigate the limited training data available. Three-second samples of EEG data were fed to the resulting matching algorithm for biometric authentication.

The results above are for the performed tasks, but biometric accuracy rates were similar for imagined and combined tasks.

Each person, wearing a commercial dry-electrode EEG headset, achieved at least 81.3 percent accuracy.

Three participants were tested in a lab, the rest were in their homes. They were in rooms dark except for a computer screen. All electronics were shut off or place in airplane mode to minimize interference.

A year ago, AI vendor Neurotechnology said it had launched a development kit for EEG biometrics.

accuracy | AI | artificial intelligence | authentication | biometrics | biometrics research | brainwave

Follow this link:

Brain wave biometrics yield 93% authentication rate in research - Biometric Update

As multiple coronavirus variants continue to be identified and drug makers seek approval for treatments, the healthcare industry is enjoying the markets attention. This is evident in the Health Care Select Sector SPDR Funds (XLV) 13.5% year-to-date returns. So, amid current market volatility, we think it could be wise to bet on quality healthcare stocks because the sector is defensive and could add stability to ones portfolio.

The prevalence of chronic diseases and an aging population are also expected to increase the need for healthcare solutions. According to a Techtic report, the global healthcare market is expected to reach $11.91 trillion by 2022.

So, we think it could be wise to bet on fundamentally sound healthcare stocks Stryker Corporation (SYK), Boston Scientific Corporation (BSX), and ResMed Inc. (RMD), which are trading below their 52-week highs now.

Click here to checkout our Healthcare Sector Report for 2021

Stryker Corporation (SYK)

Medical technology company SYK in Kalamazoo, Mich., operates through three segments: Orthopaedics; MedSurg; and Neurotechnology and Spine. The company sells its products to several healthcare facilities through company-owned subsidiaries & third-party dealers globally.

On September 7, SYK acquired Gauss Surgical, a medical device company, which developed Triton. Dylan Crotty, president of Strykers Instruments division, said, Our belief is that Triton technology will help improve the industry standards for quantifying blood loss in the labor and delivery department, furthering Strykers commitment to improve safety and outcomes for our caregivers and their patients.

SYKs net sales increased 55.4% year-over-year to $4.29 billion in the second quarter, ended June 30, 2021. Its gross profit came in at $2.77 billion, up 79.1% year-over-year. Its net earnings were $592 million compared to an $83 million loss in the year-ago period. Also, its EPS was $1.55 compared to a $0.22 loss in the previous period.

Analysts expect SYKs revenue and EPS to increase 20.4% and 25.3%, respectively, year-over-year to $17.27 billion and $9.31for its fiscal year 2021. In addition, it has surpassed the consensus EPS estimates in three of the trailing four quarters. Over the past nine months, the stock has gained 11.9% in price to close yesterdays trading session at $270.86. It is currently trading 3.7% below its 52-week high of $281.16, which it hit on September 9, 2021.

SYKs strong fundamentals are reflected in its POWR Ratings. The stock has an overall B rating, which indicates a Buy in our proprietary rating system. The POWR Ratings assess stocks by 118 distinct factors, each with its own weighting.

SYK has a B grade for Growth and Stability. Within the Medical Devices & Equipment industry, it is ranked #45 of 181 stocks. Click here to see the additional POWR Ratings for Value, Momentum, Sentiment, and Quality for SYK.

Boston Scientific Corporation (BSX)

BSX develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. The Marlborough, Mass., company operates through three segments: MedSurg; Rhythm and Neuro; and Cardiovascular.

On October 6, BSX announced its agreement to acquire Baylis Medical Company Inc. Mike Mahoney, BSXs Chairman and CEO, said, We believe that Baylis Medical Company will add meaningful revenue, operating income, and new research and development capabilities across multiple Boston Scientific businesses, while complementing existing offerings within our electrophysiology and structural heart portfolios.

BSXs net sales increased 53.6% year-over-year to $3.08 billion for its fiscal second quarter, ended June 30, 2021. The companys operating income came in at $262 million, versus a $71 million loss in the prior year. Its gross profit in the quarter was $2.13 billion, up 75.9% from the year-ago period. Also, its EPS came in at $0.12 compared to a $0.11 loss per share in the prior years quarter.

For its fiscal year 2021, analysts expect BSXs revenue to be $12 billion, representing a 21.1% year-over-year rise. The companys EPS is expected to increase 67.7% year-over-year to $1.61 in fiscal 2021. It surpassed the consensus EPS estimates in three of the trailing four quarters. Over the past nine months, the stock has gained 21.7% in price to close yesterdays trading session at $44.13. It is currently trading 4.7% below its 52-week high of $46.29, which it hit on August 2, 2021.

BSXs POWR Ratings reflect this promising outlook. The stock has an overall B rating, which equates to a Buy in our POWR Rating system. Also, the stock has an A grade for Growth.

Click here to see BSXs ratings for Value, Momentum, Stability, Sentiment, and Quality as well. Again, BSX is ranked #33 in the Medical Devices & Equipment industry.

ResMed Inc. (RMD)

RMD develops, manufactures, distributes, and markets medical devices and cloud-based software applications for the healthcare markets. The company operates in two segments, Sleep and Respiratory Care; and Software as a Service. RMD is headquartered in San Diego, Calif.

On August 16, RMD launched its AirSense 11 PAP Series, advancing digital health in sleep apnea treatment. Jim Hollingshead, the companys president of Sleep and Respiratory Care segment, said AirSense 11s new tailored features along with our myAir patient engagement app help give people the support they need to use PAPthe gold standard for treating sleep apneacomfortably and confidently every night.

RMDs revenue increased 13.7% year-over-year to $876.1 million in its fiscal fourth quarter, ended June 30, 2021. Its income from operations came in at $241.6 million, up 8.2% from the previous period. And its non-GAAP net income was $198.4 million, up 2.6% year-over-year. Also, its non-GAAP EPS came in at $1.35, up 1.5% year-over-year.

For its fiscal year 2022, RMDs revenue and EPS are expected to grow 18.6% and 17.4%, respectively, year-over-year to $3.79 billion and $6.26. It surpassed the consensus EPS estimates in each of the trailing four quarters. Over the past nine months, the stock has gained 21.1% in price to close yesterdays trading session at $260.16. It is currently trading 13.7% below its 52-week high of $301.34, which it hit on September 9, 2021.

RMDs strong fundamentals are reflected in its POWR ratings. The stock has an overall B rating, which equates to a Buy in our proprietary rating system.

In addition, it has a B grade for Stability, Sentiment, and Quality. RMD is ranked #20 in the Medical Devices & Equipment industry. Click here to see the additional POWR Ratings for RMD (Growth, Value, and Momentum).

Click here to checkout our Healthcare Sector Report for 2021

SYK shares were trading at $273.64 per share on Wednesday afternoon, up $2.78 (+1.03%). Year-to-date, SYK has gained 12.50%, versus a 22.05% rise in the benchmark S&P 500 index during the same period.

Riddhima is a financial journalist with a passion for analyzing financial instruments. With a master's degree in economics, she helps investors make informed investment decisions through her insightful commentaries. More...

Read the original here:

SYK: 3 Healthcare Stocks to Buy on the Dip - StockNews.com

LUBBOCK, Texas, Oct. 19, 2021 /PRNewswire/ --West Texas patients seeking outpatient knee replacement surgery have a new, high-quality, cost-effective choice for their care at a nationally accredited center that meets the highest standards for patient safety and quality.

Dr. David Shephard announced today the successful completion of West Texas' first outpatient robot-assisted knee replacement surgery at a free-standing ambulatory surgery center (ASC) using the Stryker MAKO surgical robot.

Dr. Shephard is a Johns Hopkins fellowship trained and board-certified orthopedic surgeon, and a partner at Lubbock Sports Medicine. He has performed more than a thousand robot-assisted knee replacements at Covenant Medical Center and Grace Surgical Hospital and welcomed the opportunity to extend this treatment option to a completely new environment.

"For appropriate candidates, an ASC is a safe, convenient, and cost-effective option, and we are proud to be the first center in West Texas to offer patients this choice," stated Dr. Shephard. "Patients who undergo robot-assisted total knee replacement at our center will often go home the same day, at most the next morning. Studies show that recovery at home can be beneficial to the patient, speeding the healing process, and reducing the risk of infection."

The Ambulatory Surgery Center Association notes that "ASCs have transformed the outpatient experience for millions of Americans by providing them with a more convenient alternative to hospital-based outpatient proceduresand done so with a strong track record of quality care and positive patient outcomes," and ASCs save Medicare and patients billions of dollars each year by offering excellent care at lower overall costs.

"The Stryker MAKO robotic platform was selected because of its strong track record of proven results," stated CHPSC Administrator Alfonso del Granado. "And now, for the first time, patients in West Texas have the option to benefit from this innovative technology in an ambulatory surgery center. Too often, patients have not been able to afford the treatment options available at large hospitals. With this new program, we are demonstrating our commitment to offer patients the best care in West Texas."

About Covenant High Plains Surgery Center, LLCCovenant High Plains Surgery Center (CHPSC) operates two freestanding, independent multispecialty ambulatory surgery centers in Lubbock, Texas. Fully accredited by the Accreditation Association for Ambulatory Health Care and by the American Society for Metabolic and Bariatric Surgery, CHPSC was created by the 2015 merger of Covenant SurgiCenter (est. 1986) and High Plains Surgery Center (est. 2006). With 14 operating and procedure rooms and more than a hundred physicians on staff, CHPSC offers the latest treatment options in dermatology, ENT, general surgery, GI, gynecology, neurosurgery, ophthalmology, orthopedics, pain, plastic & reconstructive surgery, podiatry, and urology to patients from Texas, New Mexico, and Oklahoma. For more information, visit http://www.CHPSurgery.com.

About Lubbock Sports Medicine & RehabLubbock Sports Medicine's mission is to provide the very latest treatment options for orthopedic injuries. Their focus is on active people from all walks of life, including recreational and elite level athletes. Their physicians take the time to listen to patients' needs and present them with the treatment options that will help them live the quality of life they desire. More information is available at http://www.LubbockSportsMed.com.

About StrykerStryker is one of the world's leading medical technology companies and, together with its customers, is driven to make healthcare better. The company offers innovative products and services in Orthopaedics, Medical and Surgical, and Neurotechnology and Spine that help improve patient and hospital outcomes. More information is available at http://www.Stryker.com.

About the Ambulatory Surgery Center AssociationThe Ambulatory Surgery Center Association (ASCA) assists ambulatory surgery centers (ASCs) in delivering safe, high-quality, cost-effective patient care. For more information, visit http://www.ASCAssociation.org.

SOURCE Covenant High Plains Surgery Center

http://www.chpsurgery.com

Continued here:

Covenant High Plains Surgery Center becomes West Texas' only ambulatory surgery center to perform robot-assisted total knee replacement surgery -...